Related Experiment Videos
Drug-induced parkinsonism in the elderly.
Lancet (London, England)
|November 10, 1984
Summary
Drug-induced parkinsonism (DIP) affects over half of new geriatric cases, presenting similarly to idiopathic forms. While DIP often resolves, some patients may develop idiopathic parkinsonism later.
Area of Science:
- Geriatric Medicine
- Neurology
- Clinical Pharmacology
Background:
- Parkinsonism is a complex neurological condition affecting motor control.
- Drug-induced parkinsonism (DIP) is a significant concern in geriatric populations due to polypharmacy.
Purpose of the Study:
- To investigate the prevalence and clinical characteristics of drug-induced parkinsonism in new geriatric referrals.
- To compare DIP with idiopathic parkinsonism.
- To assess the resolution and long-term outcomes of DIP.
Main Methods:
- Retrospective analysis of 95 new parkinsonism cases in a geriatric medicine department.
- Clinical assessment and drug history review for all patients.
- Comparison of features between drug-induced and idiopathic parkinsonism cohorts.
Main Results:
- 51% of new parkinsonism cases were associated with prescribed drugs.
- Clinical features, including tremor, were similar between DIP and idiopathic parkinsonism.
- 25% of DIP patients had mobility issues, and 45% required hospitalization; two-thirds of DIP cases resolved within a mean of 7 weeks, but 5 cases later developed idiopathic parkinsonism.
Conclusions:
- Prescribed drugs are a common cause of parkinsonism in the elderly, often mimicking idiopathic disease.
- DIP can lead to significant morbidity, including mobility impairment and hospitalization.
- While DIP frequently resolves, it may unmask or trigger underlying idiopathic parkinsonism in susceptible individuals.